ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Framingham Heart Study

This study is ongoing, but not recruiting participants.

Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00005121
  Purpose

The Framingham Heart Study was initiated to study the factors associated with the development of cardiovascular disease by employing long-term surveillance of an adult population in Framingham, Massachusetts. The Framingham Offspring Study was initiated to assess familial and genetic factors as determinants of coronary heart disease.


Condition
Cardiovascular Diseases
Heart Diseases
Coronary Disease
Cerebrovascular Accident
Hypertension
Heart Failure, Congestive
Peripheral Vascular Diseases
Arterial Occlusive Diseases
Atherosclerosis
Heart Failure

Genetics Home Reference related topics:   Heart Diseases   Stroke   Vascular Diseases  

MedlinePlus related topics:   Heart Diseases   Heart Failure   High Blood Pressure   Peripheral Vascular Diseases   Stroke   Vascular Diseases  

U.S. FDA Resources

Study Type:   Observational
Study Design:   Natural History, Longitudinal, Defined Population

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date:   July 1948
Estimated Study Completion Date:   September 2008

 Show Detailed Description

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

No eligibility criteria

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005121

Sponsors and Collaborators

Investigators
Investigator:     Philip Wolf     Boston University    
Investigator:     Philip Wolf     Boston University    
  More Information

Related Info  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   900
First Received:   May 25, 2000
Last Updated:   August 8, 2005
ClinicalTrials.gov Identifier:   NCT00005121
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Atherosclerosis
Arterial Occlusive Diseases
Heart Failure
Heart Diseases
Peripheral Vascular Diseases
Cerebral Infarction
Myocardial Ischemia
Stroke
Vascular Diseases
Central Nervous System Diseases
Ischemia
Arteriosclerosis
Brain Diseases
Cerebrovascular Disorders
Coronary Disease
Brain Ischemia
Brain Infarction
Infarction
Hypertension

Additional relevant MeSH terms:
Nervous System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 12, 2008